School of Pharmacy
We are a tight-knit, multidisciplinary group of researchers who study age-related macular degeneration (AMD). Our group is led by the world-renowned Professor Kai Kaarniranta (M.D.; Ph.D.; Chief Physician at the Department of Ophthalmology, Kuopio University Hospital (KUH); Head of Ophthalmology ...
Project Researcher, Institute of Clinical Medicine
University Teacher , Biomedicine
Postdoctoral Researcher , School of Pharmacy
Early Stage Researcher , School of Pharmacy
01.07.2020 - 31.12.2024GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
Inflammation is associated with various chronic diseases many of which have insufficient treatment options. Along with inflammatory signaling, we study more broadly cellular events in order to reveal molecular mechanisms and dysfunctionalities behind the pathogenesis of inflammatory diseases.
Senior Researcher , School of Pharmacy